Abstract
Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 126-131 |
| Number of pages | 6 |
| Journal | Methodist DeBakey cardiovascular journal |
| Volume | 13 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jul 1 2017 |
Keywords
- SAVR
- TAVR
- expandable valve
- surgical aortic valve replacement
- transcatheter aortic valve replacement
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS